Changes in Serum IL-2 Levels Following a Single Oral Dose of Gluten
Boston Children's Hospital
Summary
This is a study of immune responses after eating gluten powder in people with celiac disease and healthy controls.
Description
This is a multi-site open-label single dose gluten challenge study. Participants will provide a blood sample for measurement of cytokines before and 4 hours after eating gluten powder.
Eligibility
- Age range
- 2–101 years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: 1. On a gluten-free diet for ≥ 4 weeks 2. Willing to consume gluten for research 3. For the celiac disease arm, diagnosis confirmed by serology and/or histology Exclusion Criteria: 1. Pregnancy 2. Wheat allergy 3. Type 1 diabetes 4. BMI z-score \< -2 5. History of more than minimal symptoms following gluten exposure on a gluten-free diet 6. Comorbid condition that in the opinion of the investigator would interfere with study participation or would confound study results
Interventions
- Dietary SupplementGluten Powder
Single oral dose of gluten powder
Locations (2)
- Children's Hospital ColoradoAurora, Colorado
- Boston Children's HospitalBoston, Massachusetts